This Million Targets Drug: A $7M Bet on a CNS Breakthrough
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
This guide explains Zero Based Budgeting for beginners. Understand the basics and start managing your finances with confidence.
15,882 articlesA focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Palantir often looks pricey at first glance, but the real story may be hidden in growth engines and future contracts....
A federal probe into Tesla's FSD system raises questions for investors about safety, costs, and stock risk. This guid...
Playnance’s G Coin has breached the one-million-holders threshold, underscoring rapid early adoption as staking and e...
BitGo expands institutional access by enabling OTC entry to prediction markets through a new alliance with Susquehann...
The Roundhill COSW ETF remains focused on generating weekly income by selling calls on COST, a structure that caps ga...
A top Interface executive dumped stock in a move worth hundreds of thousands. Is this a signal about the business or ...
Timken stands at a pivotal moment as it reports Q1 2026 earnings. This guide breaks down the business mix, growth dri...
What to watch in jfrog (frog) 2026 earnings: ARR trends, cloud mix, and expansion strategy. This guide translates the...
Biotech earnings season shines a spotlight on Delcath Systems. This guide breaks down the 2026 earnings outlook, key ...
IonQ just posted revenue that more than tripled for the third straight quarter, but the stock sold off despite the ga...
When a tech giant faces a costly lawsuit over a celebrity image, it isn’t just a legal story—it’s a personal finance ...